Your browser doesn't support javascript.
loading
Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.
Dupéré-Richer, Daphné; Kinal, Mena; Pettersson, Filippa; Emond, Audrey; Calvo-Vidal, M Nieves; Nichol, Jessica N; Guilbert, Cynthia; Plourde, Dany; Klein Oros, Kathleen; Nielsen, Torsten H; Ezponda, Teresa; Licht, Jonathan D; Johnson, Nathalie A; Assouline, Sarit; Cerchietti, Leandro; Miller, Wilson H; Mann, Koren K.
Afiliación
  • Dupéré-Richer D; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Kinal M; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Pettersson F; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Emond A; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Calvo-Vidal MN; b Division of Hematology and Oncology, Department of Medicine , Cornell University , New York , NY, USA.
  • Nichol JN; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Guilbert C; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Plourde D; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Klein Oros K; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Nielsen TH; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Ezponda T; c Division of Hematology/Oncology , Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine , Chicago , IL, USA.
  • Licht JD; c Division of Hematology/Oncology , Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine , Chicago , IL, USA.
  • Johnson NA; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Assouline S; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Cerchietti L; b Division of Hematology and Oncology, Department of Medicine , Cornell University , New York , NY, USA.
  • Miller WH; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
  • Mann KK; a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
Leuk Lymphoma ; 58(1): 218-221, 2017 01.
Article en En | MEDLINE | ID: mdl-27185211
Asunto(s)
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Perfilación de la Expresión Génica / Inhibidores de Histona Desacetilasas / Inhibidores de Proteasoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Perfilación de la Expresión Génica / Inhibidores de Histona Desacetilasas / Inhibidores de Proteasoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article